300323.SZ
300323.SZ
CNE100001DV3
HC SEMITEK
Loading chart...
Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 45/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.7x).

Beta (Market Relation)
0.68x
Defensive
Volatility (5Y p.a.)
55.1% p.a.
5-Year Horizon
Max Drawdown (5Y)
-71.1%
5-Year Horizon
Sharpe Ratio
-0.16
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Volatility Expansion (3Y > 5Y) High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — +7.6%
3 Years 64.6% -56.7% 0.17 +13.5%
5 Years 55.1% -71.1% -0.16 -5%
10 Years 55.4% -83.3% -0.03 +0.6%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
Elevated Short-Term Volatility: 3Y volatility (64.6%) is noticeably higher than the 5Y average (55.1%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (55.1% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -83.3% in the extended horizon.
ende